Endothelial cell-specific ETB receptor knockout: autoradiographic and histological characterisation and crucial role in the clearance of endothelin-1

Canadian Journal of Physiology and Pharmacology
N F KellandD J Webb

Abstract

Inactivation of endothelin B receptors (ETB), either through selective pharmacological antagonism or genetic mutation, increases the circulating concentration of endothelin-1 (ET-1), suggesting ETB plays an important role in clearance of this peptide. However, the cellular site of ETB-mediated clearance has not yet been determined. We have used a novel mouse model of endothelial cell-specific knockout (KO) of ETB (EC ETB(-/-)) to evaluate the relative contribution of EC-ETB to the clearance of ET-1. Phenotypic evidence of EC-specific ETB KO was confirmed by immunocytochemistry and autoradiography. Binding of the radiolabelled selective ETB ligand BQ3020 was significantly and selectively decreased in EC-rich tissues of EC ETB(-/-) mice, including the lung, liver, and kidney. By contrast, ETA binding was unaltered. RT-PCR confirmed equal expression of ET-1 in tissue from EC ETB(-/-) mice and controls, despite increased concentration of plasma ET-1 in EC ETB(-/-). Clearance of an intravenous bolus of [(125)I]ET-1 was impaired in EC ETB(-/-) mice. Pretreatment with the selective ETB antagonist A192621 impaired [(125)I]ET-1 clearance in control animals to a similar extent, but did not further impair clearance in EC ETB(-/-) mice. Th...Continue Reading

References

Jul 1, 1992·Hypertension·Z A AbassiH R Keiser
Apr 17, 1995·Biochemical and Biophysical Research Communications·S OzakiM Yano
Jan 1, 1994·British Journal of Pharmacology·A P DavenportA M Doherty
Mar 30, 1994·Biochemical and Biophysical Research Communications·T FukurodaM Nishikibe
Apr 5, 2000·The Journal of Clinical Investigation·C E GariepyM Yanagisawa
Feb 13, 2001·Developmental Biology·Y Y KisanukiM Yanagisawa
Jun 16, 2001·American Journal of Physiology. Renal Physiology·D M Pollock, J S Pollock
Sep 17, 2002·Methods : a Companion to Methods in Enzymology·Diona L Damian, Gary M Halliday
Mar 4, 2003·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Traci A TaylorJennifer S Pollock
Apr 24, 2003·Clinical Science·Anh Thu Tran DucJocelyn Dupuis
May 10, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Jean-Claude HonoréPedro D'Orleans-Juste
Jul 27, 2006·American Journal of Physiology. Renal Physiology·Yuqiang GeDonald E Kohan

❮ Previous
Next ❯

Citations

Apr 3, 2012·Cardiovascular Research·Nicholas S KirkbyPatrick W F Hadoke
Feb 21, 2013·Cardiology in Review·Theofilos M KolettisYasuo Matsumura
Jan 20, 2012·Current Opinion in Nephrology and Hypertension·Yohann Rautureau, Ernesto L Schiffrin
Jul 31, 2012·Cardiology Research and Practice·Sofia-Iris BibliTheofilos M Kolettis
Mar 10, 2016·Pharmacological Reviews·Anthony P DavenportJanet J Maguire
Sep 18, 2015·Particle and Fibre Toxicology·Prem KumarathasanRenaud Vincent
Dec 4, 2012·Free Radical Biology & Medicine·Olga RafikovaStevan P Tofovic
May 13, 2015·Seminars in Nephrology·Janet J Maguire, Anthony P Davenport
Nov 9, 2017·Frontiers in Pharmacology·Robert M Rapoport, Daphne Merkus
Nov 10, 2017·Acta Pharmacologica Sinica·Oliver BaretellaPaul M Vanhoutte
Aug 29, 2012·Nature Reviews. Nephrology·Hani M Wadei, Stephen C Textor
Sep 6, 2012·British Journal of Pharmacology·Faye M DrawnelH Llewelyn Roderick
Aug 6, 2017·Molecular Pharmacology·Emilia KansanenAnna-Liisa Levonen
Aug 19, 2014·British Journal of Pharmacology·J J Maguire, A P Davenport
Mar 4, 2011·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Stephane L BourqueMichael A Adams
Jan 31, 2020·Physiological Reviews·Jens Leipziger, Helle Praetorius
Jan 31, 2018·Physiological Reports·Philipp BaumannVincenzo Cannizzaro
Aug 3, 2018·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Tsering StobdanGabriel G Haddad
Dec 17, 2020·Physiology·Lauren G DoumaMichelle L Gumz
Sep 1, 2018·Vascular Pharmacology·Damian KloskaAnna Grochot-Przeczek
Feb 8, 2011·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Fernando Rodríguez-PascualSantiago Lamas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.